The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis
Stereotactic ablative radiotherapy (SABR) achieves excellent local control, minimal toxicity, and acceptable renal function impact despite larger primary RCCs in older, mostly inoperable patients. This non-invasive, outpatient treatment may represent an alternative for selected patients with primary RCC.
